Skip to main content
OpenTrials
Completed

NCT Number: NCT01468194

Change in Peripheral Oxygen Saturation by Using Different Breathing Procedures in High Altitude

In this investigation the researchers explore whether different types of breathing procedures can improve the peripheral oxygen saturation to reduce the risk of becoming a acute mountain sickness or a high altitude pulmonary edema.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Giessen

Giessen, Hesse, 35394, Germany

About this study

Acute mountain sickness (AMS) is a pathological effect of high altitude on humans caused by acute exposure to low partial pressure of oxygen at high altitude. It commonly occurs above 2500 meters of altitude. AMS appears as a collection of nonspecific symptoms acquired at high altitude or in low air pressure resembling a case of "flu, carbon monoxide poisoning, or a hangover".

It is caused by a drop in pressure and lowering partial pressure of oxygen during increasing altitude. The direct consequence of those changes is a hypoxic pulmonary vasoconstriction (Euler-Lijestrand-mechanism). In addition a rise in pulmonary blood pressure (Hypertonia) can occur so that there is a higher risk of developing a high altitude pulmonary edema (HAPE).

In this investigation the investigators are exploring whether different types of breathing procedures can improve the peripheral oxygen saturation. We are comparing breathing with no regulation with two different procedures of hyperventilation during trekking in different altitudes. Procedure 1 (hyperventilation 1) describes inhalation during one step and exhalation during the next step. Procedure 2 (hyperventilation 2) describes inhalation and exhalation during one step.

The effect of the different breathing procedures can be quantified measuring the peripheral oxygen saturation. In addition the investigators are comparing the breathing rate and the minute ventilation as well as the expiratory end-tidal CO2-partial pressure of the three different breathing procedures.

Furthermore, the investigators are examining the ability to concentrate in order to quantify the effect of AMS on organ functions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Exclusion criteria

  • acute clinically significant inter-current diseases

Treatment and study plan

Breathing procedure 1

Other

inhalation during one step, exhalation during the next step

Breathing procedure 2

Other

inhalation and exhalation during one step

Primary outcomes

  1. change of peripheral oxygen saturation

    Time frame: immediate after intervention

    change of peripheral oxygen saturation under different breathing procedures in different altitudes

Secondary outcomes

  1. change of breathing parameters

    Time frame: immediate after intervention

    change of breathing parameters under different breathing procedures in different altitudes

    • breathing rate
    • minute ventilation
    • expiratory end-tidal CO2-partial pressure
  2. change of cognition

    Time frame: immediate after intervention

    change of ability of cognition (measured by d2-test) under different breathing procedures in different altitudes

Sponsors and collaborators

Lead sponsor

University of Giessen

Other

Collaborators

  • MVZ für Laboratoriumsmedizin Koblenz

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Nov 9, 2011
Registry last updated
Nov 9, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.